These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33728800)

  • 1. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure.
    Rumery K; Seo A; Jiang L; Choudhary G; Shah NR; Rudolph JL; Wu WC; Erqou S
    ESC Heart Fail; 2021 Jun; 8(3):2338-2344. PubMed ID: 33728800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
    Tomasoni D; Inciardi RM; Lombardi CM; Tedino C; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Volterrani M; Zaccone G; Guazzi M; Senni M; Metra M
    Eur J Heart Fail; 2020 Dec; 22(12):2238-2247. PubMed ID: 33179839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry.
    Keshvani N; Mehta A; Alger HM; Rutan C; Williams J; Zhang S; Young R; Alhanti B; Chiswell K; Greene SJ; DeVore AD; Yancy CW; Fonarow GC; Pandey A
    Eur J Heart Fail; 2022 Jun; 24(6):1117-1128. PubMed ID: 35289038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
    Steinberg BA; Zhao X; Heidenreich PA; Peterson ED; Bhatt DL; Cannon CP; Hernandez AF; Fonarow GC;
    Circulation; 2012 Jul; 126(1):65-75. PubMed ID: 22615345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables.
    Silva GC; Jiang L; Gutman R; Wu WC; Mor V; Fine MJ; Kressin NR; Trivedi AN
    JAMA Intern Med; 2020 Mar; 180(3):347-355. PubMed ID: 31860015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure Outcomes and Associated Factors Among Veterans With Human Immunodeficiency Virus Infection.
    Erqou S; Jiang L; Choudhary G; Lally M; Bloomfield GS; Zullo AR; Shireman TI; Freiberg M; Justice AC; Rudolph J; Lin N; Wu WC
    JACC Heart Fail; 2020 Jun; 8(6):501-511. PubMed ID: 32278680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland.
    Terlecki M; Wojciechowska W; Klocek M; Olszanecka A; Stolarz-Skrzypek K; Grodzicki T; Małecki M; Katra B; Garlicki A; Bociąga-Jasik M; Sładek K; Matyja A; Wordliczek J; Słowik A; Mach T; Krzanowska K; Krzanowski M; Stręk P; Chłosta P; Hydzik P; Korkosz M; Popiela T; Pilecki M; Gądek A; Rajzer M
    Kardiol Pol; 2021; 79(7-8):773-780. PubMed ID: 33926173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19.
    Goyal P; Reshetnyak E; Khan S; Musse M; Navi BB; Kim J; Allen LA; Banerjee S; Elkind MSV; Shah SJ; Yancy C; Michos ED; Devereux RB; Okin PM; Weinsaft JW; Safford MM
    Circ Heart Fail; 2021 Sep; 14(9):e008354. PubMed ID: 34517720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry.
    Panagides V; Vincent F; Weizman O; Jonveaux M; Trimaille A; Pommier T; Cellier J; Geneste L; Marsou W; Deney A; Attou S; Delmotte T; Fauvel C; Ezzouhairi N; Perin B; Zakine C; Levasseur T; Ma I; Chavignier D; Noirclerc N; Darmon A; Mevelec M; Karsenty C; Duceau B; Sutter W; Mika D; Pezel T; Waldmann V; Ternacle J; Cohen A; Bonnet G;
    Arch Cardiovasc Dis; 2021 May; 114(5):415-425. PubMed ID: 34099379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the COVID-19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis.
    Morishita T; Takada D; Shin JH; Higuchi T; Kunisawa S; Fushimi K; Imanaka Y
    ESC Heart Fail; 2022 Feb; 9(1):31-38. PubMed ID: 34913269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Clinical Characteristics and 2-Year Prognosis of Patients with Heart Failure Grouped by Left Ventricular Ejection Fraction Status.
    Wang C; Zhou Y; Zhong R; Bao Y; Li Z; Tian J
    Int Heart J; 2020 Nov; 61(6):1236-1244. PubMed ID: 33191350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.